Abstract

Patients with metastasized colorectal cancer enrolled in a phase III chemotherapy trial had better survival and lower progression rates if they engaged in a half hour of moderate physical activity each day, according to an analysis of subjects conducted by the Alliance for Clinical Trials in Oncology.